Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass A - Therapeutic

ESC Medication Library · Revision 2

← Medication library · Compare sanctioning bodies

Medication Facts

Performance enhancing
No
Total hours to clear
Not recorded
Frequently used
N/A
ESC ID
DIPYRO-0311
Trade names
Metamizole
Drug type
Analgesic/Antipyretic
Plasma half-life · hours
4
Equine dosing
Consult veterinarian
Cmax · peak plasma concentration
4
Tmax · time to peak plasma concentration
4
ESC concentration guidance
May not exceed 6% efficacy in plasma
Primary withdrawal · hours
12
Washout withdrawal · hours
0
ESC control type
A1 - Generally Controlled - Therapeutic
Medication report required
Generally not required, however understand exceptions.

Uses & side effects

Product-specific side effects await source review.

Drug interactions

Analgesic and antipyretic medications in horses interact most critically with corticosteroids, aminoglycoside antibiotics, and other drugs that stress the kidneys or gastrointestinal tract, risking severe organ damage or fatal toxicities. In equine medicine, these medications are primarily Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as phenylbutazone ("Bute"), flunixin meglumine ("Banamine"), firocoxib (Equioxx), and ketoprofen, alongside non-NSAID options like acetaminophen (often used for fever or chronic pain) and dipyrone. Because horses have a highly sensitive gastrointestinal tract and unique renal physiology, stacking these compounds with interacting drugs requires careful monitoring.The most important equine drug interactions for analgesics and antipyretics are detailed below:1. Corticosteroids (Dual-Anti-inflammatory Stacking)Medications: Dexamethasone, Prednisolone, Triamcinolone.The Interaction: Combining any NSAID analgesic with a corticosteroid creates a severe pharmacodynamic interaction that exponentially increases systemic toxicity. Both drug classes inhibit prostaglandins, which are essential for maintaining the protective mucosal lining of the horse's gut and ensuring proper blood flow to the kidneys.Clinical Impact: Severe risk. Co-administration rapidly triggers severe gastrointestinal ulceration (gastric ulcers and right dorsal colitis), protein-losing enteropathy, and acute renal papillary necrosis (kidney failure).2. Nephrotoxic Antibiotics (Kidney Strain)Medications: Aminoglycosides (Gentamicin, Amikacin).The Interaction: Aminoglycoside antibiotics are highly effective but inherently stressful to the equine kidneys. NSAIDs reduce renal blood flow by inhibiting vasodilatory prostaglandins (\(PGE_{2}\) and \(PGI_{2}\)), which normally protect the kidneys during periods of dehydration or stress.Clinical Impact: High risk. When a horse receives Gentamicin while on therapeutic doses of Bute or Banamine, the reduced blood flow traps the antibiotic in the renal cortex. This drastically accelerates acute kidney injury (AKI), especially in dehydrated, endotoxemic, or neonatal foals.3. Multiple NSAID Stacking ("Double Dosing")Medications: Combining Bute with Banamine, or Firocoxib with Bute.The Interaction: Concurrent use of two different NSAIDs does not provide a synergistic pain-relieving effect. Instead, it over-saturates the cyclooxygenase (COX-1 and COX-2) pathways.Clinical Impact: Critical risk. This is a frequent cause of accidental poisoning in horses. It severely multiplies the risk of right dorsal colitis (ulceration of the large colon), oral ulcers, and renal failure without offering any extra pain relief.4. Acetaminophen and Hepatic/Renal InteractionsAcetaminophen is increasingly utilized in horses for laminitis pain and fever reduction when NSAID use is restricted.Liver-Metabolized Drugs: Medications that inhibit or induce cytochrome P450 liver enzymes (like cimetidine or rifampin) can alter how acetaminophen is broken down.Clinical Impact: Moderate to High. In humans, acetaminophen overdose is notoriously hepatotoxic; in horses, while the liver is at risk, it can also cause profound methemoglobinemia (where red blood cells cannot carry oxygen efficiently) and secondary kidney damage if paired with other hepatotoxic or nephrotoxic agents.5. Anticoagulants and AntiplateletsMedications: Heparin, Aspirin, Clopidogrel.The Interaction: NSAID analgesics inherently interfere with platelet aggregation to varying degrees (Bute and Banamine are non-selective and have higher antiplatelet effects than COX-2 selective Firocoxib).Clinical Impact: High risk. Stacking an analgesic with an anticoagulant severely impairs the horse's clotting cascade while simultaneously weakening the GI lining, frequently leading to spontaneous internal bleeding or severe bleeding from minor injection sites.

Contraindications

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

UCG 20.0 PDF p. 25

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Drug Class 4 · Penalty Class C. No dosing permission is implied by classification.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.